I‐Ping Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
-
- MicroRNA in disease regulation 9
- Cancer, Hypoxia, and Metabolism 1
- Oncology 7
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Surgical Treatments 2
- Co-authors
- Jaw‐Yuan Wang (19 shared papers)Hsiang‐Lin Tsai (17 shared papers)Suh‐Hang Hank Juo (12 shared papers)Ching‐Wen Huang (8 shared papers)Pei‐Chien Tsai (3 shared papers)Ming‐Feng Hou (4 shared papers)Zhi‐Feng Miao (5 shared papers)Yung‐Sung Yeh (8 shared papers)
- Journals
- PLoS ONE (3 papers)Journal of Cellular and Molecular Medicine (1 paper)Carcinogenesis (1 paper)Clinica Chimica Acta (1 paper)Journal of Surgical Oncology (1 paper)
- Partner nations
- Taiwan
In The Last Decade
I‐Ping Yang
20 papers receiving 596 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 298
- Oncology 158
- Molecular Biology 176
- Pathology and Forensic Medicine 27
- Clinical Biochemistry 4
Countries citing papers authored by I‐Ping Yang
This map shows the geographic impact of I‐Ping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ping Yang more than expected).
Fields of papers citing papers by I‐Ping Yang
This network shows the impact of papers produced by I‐Ping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ping Yang. The network helps show where I‐Ping Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Ping Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 80 | |
| 2 | 2013 | 58 | |
| 3 | 2012 | 56 | |
| 4 | 2013 | 48 | |
| 5 | 2016 | 47 | |
| 6 | 2013 | 44 | |
| 7 | 2016 | 39 | |
| 8 | 2019 | 39 | |
| 9 | 2016 | 38 | |
| 10 | 2012 | 29 | |
| 11 | 2010 | 25 | |
| 12 | 2019 | 18 | |
| 13 | 2012 | 17 | |
| 14 | 2022 | 15 | |
| 15 | 2013 | 13 | |
| 16 | 2014 | 12 | |
| 17 | Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients. | 2015 | 12 |
| 18 | 2023 | 10 | |
| 19 | 2012 | 5 | |
| 20 | 2016 | 2 |
About I‐Ping Yang
I‐Ping Yang is a scholar working on Cancer Research, Oncology, Molecular Biology, Genetics and Nutrition and Dietetics, having authored 20 papers that have together received 607 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Colorectal Cancer Treatments and Studies (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Colorectal Cancer Surgical Treatments (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Gene expression and cancer classification (1 paper) and Genomic variations and chromosomal abnormalities (1 paper). The work is most often cited by research in Cancer Research (298 citations), Oncology (158 citations), Molecular Biology (176 citations), Pathology and Forensic Medicine (27 citations) and Clinical Biochemistry (4 citations). I‐Ping Yang has collaborated with scholars based in Taiwan. Frequent co-authors include Jaw‐Yuan Wang, Hsiang‐Lin Tsai, Suh‐Hang Hank Juo, Ching‐Wen Huang, Pei‐Chien Tsai, Ming‐Feng Hou, Zhi‐Feng Miao, Yung‐Sung Yeh, Chien‐Yu Lu and Chao‐Hung Kuo. Their work appears in journals such as PLoS ONE, Journal of Cellular and Molecular Medicine, Carcinogenesis, Clinica Chimica Acta and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.